Search results
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe drug is a multi-selective non-covalent inhibitor designed to treat patients with cancers driven by a wide range of common RAS mutations. ...clinical...
Community ordinances are clashing with Michigan’s drug harm reduction strategy
Detroit Free Press via Yahoo News· 4 days agoTo find a complete list of syringe service programs, go to rb.gy/osre70 Relapse. Overdose. Saving...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
WJTV Jackson· 2 days agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt from the EIB, obtained in March. This cash position, and other secured funding sources ...
US FDA approves expanded use of Bristol Myers' cancer cell therapy
Reuters· 2 days ago, opens new tab cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer...
My doctor told me I had dandruff but the lumps were cancer
Yahoo Life UK· 1 day agoFind out more at the research and advocacy charity Leukaemiauk.org.uk. Read more I was going down...
Earnings call: Bio-Path Holdings reports promising Q1 2024 results By Investing.com
Investing.com· 2 days agoBio-Path Holdings (NASDAQ: NASDAQ:BPTH), a biotechnology company focused on developing therapeutic...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 2 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
Do You Experience 'Euphoric Recall'? Here's Why It Can Be Toxic.
HuffPost Life via Yahoo News· 2 days agoRemembering bad times in a positive light is certainly understandable, but it may not be in your...
In hundreds of deadly encounters, police broke safety guidelines
NBC Los Angeles· 3 days agoIn hundreds of deaths where police used force meant to stop someone without killing them, officers...
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 3 days agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid...